Compare MLAB & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLAB | PACB |
|---|---|---|
| Founded | 1982 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.8M | 459.0M |
| IPO Year | 1995 | 2010 |
| Metric | MLAB | PACB |
|---|---|---|
| Price | $75.82 | $1.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $94.00 | $2.10 |
| AVG Volume (30 Days) | 81.0K | ★ 5.9M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | ★ 99.24 | N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $6.07 | $11.22 |
| Revenue Next Year | $5.41 | $12.41 |
| P/E Ratio | $44.66 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $59.63 | $0.85 |
| 52 Week High | $130.12 | $2.73 |
| Indicator | MLAB | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 29.53 | 36.50 |
| Support Level | $69.46 | $1.36 |
| Resistance Level | $81.62 | $1.51 |
| Average True Range (ATR) | 4.14 | 0.10 |
| MACD | -1.89 | -0.01 |
| Stochastic Oscillator | 6.32 | 22.92 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.